ANI Pharmaceuticals Statistics

Total Valuation

BST:BSFA has a market cap or net worth of EUR 1.47 billion. The enterprise value is 1.78 billion.

Market Cap	1.47B
Enterprise Value	1.78B

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.90M
Shares Outstanding	n/a
Shares Change (YoY)	+6.95%
Shares Change (QoQ)	+3.87%
Owned by Insiders (%)	7.69%
Owned by Institutions (%)	103.79%
Float	18.85M

Valuation Ratios

The trailing PE ratio is 50.49 and the forward PE ratio is 10.30.

PE Ratio	50.49
Forward PE	10.30
PS Ratio	2.08
PB Ratio	3.41
P/TBV Ratio	n/a
P/FCF Ratio	11.07
P/OCF Ratio	10.10
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.02, with an EV/FCF ratio of 13.40.

EV / Earnings	61.12
EV / Sales	2.50
EV / EBITDA	14.02
EV / EBIT	38.56
EV / FCF	13.40

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 1.25.

Current Ratio	2.58
Quick Ratio	1.94
Debt / Equity	1.25
Debt / EBITDA	4.28
Debt / FCF	4.06
Interest Coverage	1.63

Financial Efficiency

Return on equity (ROE) is 8.66% and return on invested capital (ROIC) is 3.05%.

Return on Equity (ROE)	8.66%
Return on Assets (ROA)	2.49%
Return on Invested Capital (ROIC)	3.05%
Return on Capital Employed (ROCE)	4.72%
Revenue Per Employee	785,674
Profits Per Employee	32,446
Employee Count	897
Asset Turnover	0.61
Inventory Turnover	2.20

Taxes

In the past 12 months, BST:BSFA has paid 8.51 million in taxes.

Income Tax	8.51M
Effective Tax Rate	19.74%

Stock Price Statistics

The stock price has increased by +31.13% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+31.13%
50-Day Moving Average	75.43
200-Day Moving Average	64.76
Relative Strength Index (RSI)	39.33
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.57

Income Statement

In the last 12 months, BST:BSFA had revenue of EUR 704.75 million and earned 29.10 million in profits. Earnings per share was 1.43.

Revenue	704.75M
Gross Profit	428.14M
Operating Income	45.74M
Pretax Income	43.08M
Net Income	29.10M
EBITDA	123.64M
EBIT	45.74M
Earnings Per Share (EPS)	1.43

Full Income Statement

Balance Sheet

The company has 231.37 million in cash and 538.30 million in debt, giving a net cash position of -306.92 million.

Cash & Cash Equivalents	231.37M
Total Debt	538.30M
Net Cash	-306.92M
Net Cash Per Share	n/a
Equity (Book Value)	431.11M
Book Value Per Share	20.62
Working Capital	364.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 145.50 million and capital expenditures -12.77 million, giving a free cash flow of 132.73 million.

Operating Cash Flow	145.50M
Capital Expenditures	-12.77M
Free Cash Flow	132.73M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.75%, with operating and profit margins of 6.49% and 4.91%.

Gross Margin	60.75%
Operating Margin	6.49%
Pretax Margin	6.11%
Profit Margin	4.91%
EBITDA Margin	17.54%
EBIT Margin	6.49%
FCF Margin	18.83%

Dividends & Yields

BST:BSFA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	3.85%
Buyback Yield	-6.95%
Shareholder Yield	-6.95%
Earnings Yield	1.98%
FCF Yield	9.03%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:BSFA has an Altman Z-Score of 1.9 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.9
Piotroski F-Score	7